An updated overview of diabetic nephropathy: Diagnosis, prognosis, treatment goals and latest guidelines
- PMID: 32267079
- DOI: 10.1111/dom.14007
An updated overview of diabetic nephropathy: Diagnosis, prognosis, treatment goals and latest guidelines
Abstract
Diabetic nephropathy (DN) is a major healthcare challenge. It occurs in up to 50% of those living with diabetes, is a major cause of end-stage kidney disease (ESKD) that requires treatment with dialysis or renal transplantation, and is associated with significantly increased cardiovascular morbidity and mortality. DN is a clinical syndrome characterized by persistent albuminuria and a progressive decline in renal function, but it is increasingly recognized that the presentation and clinical course of kidney disease in diabetes is heterogeneous. The term diabetic kidney disease (DKD) is now commonly used to encompass the spectrum of people with diabetes who have either albuminuria or reductions in renal function. In this article, the clinical presentation and approach to diagnosis of DKD will be discussed, as will its prognosis. The general principles of management of DKD will also be reviewed with reference to current international guidelines.
© 2020 The Authors. Diabetes, Obesity and Metabolism published by John Wiley & Sons Ltd.
Similar articles
-
Diabetic kidney disease: New clinical and therapeutic issues. Joint position statement of the Italian Diabetes Society and the Italian Society of Nephrology on "The natural history of diabetic kidney disease and treatment of hyperglycemia in patients with type 2 diabetes and impaired renal function".Nutr Metab Cardiovasc Dis. 2019 Nov;29(11):1127-1150. doi: 10.1016/j.numecd.2019.07.017. Epub 2019 Oct 2. Nutr Metab Cardiovasc Dis. 2019. PMID: 31586514 Review.
-
[Managing diabetic kidney disease].Ther Umsch. 2020 Sep;77(7):333-338. doi: 10.1024/0040-5930/a001200. Ther Umsch. 2020. PMID: 32996426 German.
-
Diabetic Nephropathy: An Overview.Methods Mol Biol. 2020;2067:3-7. doi: 10.1007/978-1-4939-9841-8_1. Methods Mol Biol. 2020. PMID: 31701441
-
Diabetic kidney disease: new clinical and therapeutic issues. Joint position statement of the Italian Diabetes Society and the Italian Society of Nephrology on "The natural history of diabetic kidney disease and treatment of hyperglycemia in patients with type 2 diabetes and impaired renal function".J Nephrol. 2020 Feb;33(1):9-35. doi: 10.1007/s40620-019-00650-x. J Nephrol. 2020. PMID: 31576500 Free PMC article. Review.
-
Risk of Progression of Nonalbuminuric CKD to End-Stage Kidney Disease in People With Diabetes: The CRIC (Chronic Renal Insufficiency Cohort) Study.Am J Kidney Dis. 2018 Nov;72(5):653-661. doi: 10.1053/j.ajkd.2018.02.364. Epub 2018 May 18. Am J Kidney Dis. 2018. PMID: 29784612
Cited by
-
Association Between Lipoprotein (A) and Diabetic Nephropathy in Patients With Type 2 Diabetes Mellitus: A Meta-Analysis.Front Endocrinol (Lausanne). 2021 Mar 24;12:633529. doi: 10.3389/fendo.2021.633529. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 33841331 Free PMC article.
-
The promising significance of liraglutide combined with dapagliflozin or empagliflozin in the prevention of early diabetic nephropathy.Am J Transl Res. 2022 Aug 15;14(8):5622-5629. eCollection 2022. Am J Transl Res. 2022. PMID: 36105007 Free PMC article.
-
Research progress of natural active compounds on improving podocyte function to reduce proteinuria in diabetic kidney disease.Ren Fail. 2023;45(2):2290930. doi: 10.1080/0886022X.2023.2290930. Epub 2023 Dec 11. Ren Fail. 2023. PMID: 38073545 Free PMC article. Review.
-
Kidney Biopsy in Type 2 Diabetic Patients: Critical Reflections on Present Indications and Diagnostic Alternatives.Int J Mol Sci. 2021 May 21;22(11):5425. doi: 10.3390/ijms22115425. Int J Mol Sci. 2021. PMID: 34063872 Free PMC article. Review.
-
Prevalence and Risk Factors of Diabetic Nephropathy Among Saudi Type-1 Diabetic Patients in Taif City, Saudi Arabia.Diabetes Metab Syndr Obes. 2023 Nov 9;16:3609-3616. doi: 10.2147/DMSO.S432700. eCollection 2023. Diabetes Metab Syndr Obes. 2023. PMID: 37964940 Free PMC article.
References
REFERENCES
-
- Byrne C, Caskey F, Castledine C, et al. UK Renal Registry: 20th Annual Report of the Renal Association. Nephron. 2018;139(suppl1):24-35.
-
- Koye DN, Shaw JE, Reid CM, Atkins RC, Reutens AT, Magliano DJ. Incidence of chronic kidney disease among people with diabetes: a systematic review of observational studies. Diabet Med. 2017;34(7):887-901.
-
- Andrésdóttir G, Jensen ML, Carstensen B, et al. Improved prognosis of diabetic nephropathy in type 1 diabetes. Kidney Int. 2015;87(2):417-426.
-
- Astrup AS, Tarnow L, Rossing P, Pietraszek L, Riis Hansen P, Parving HH. Improved prognosis in type 1 diabetic patients with nephropathy: a prospective follow-up study. Kidney Int. 2005;68(3):1250-1257.
-
- Perkins BA, Ficociello LH, Silva KH, Finkelstein DM, Warram JH, Krolewski AS. Regression of microalbuminuria in type 1 diabetes. N Engl J Med. 2003;348(23):2285-2293.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical